IJ Psychiatry and Behavioral Sciences
IJPBS is the Official Journal of Mazandaran University of Medical Sciences
Outlines
A Commentary on a Health Concern in Iran with an Emphasis on Theories
Footnotes
References
- 1.Shafiee SA, Razaghi E, Vedadhir AA. Multi-level approach to theories of addiction: A critical review. Iran J Psychiatr Behav Sci. 2019;13(2). e88881. https://doi.org/10.5812/ijpbs.88881.
- 2.Tavakoli M, Effatpanah M, Moradi A, Mahjoub A. Methamphetamine dependence among Iranian female methadone patients: A cross-sectional survey of three cities of Iran. Iran J Psychiatr Behav Sci. 2018;12(2). https://doi.org/10.5812/ijpbs.62866.
- 3.Rafiey H, Ghaderi S, Morovat B, Noori R, Effatpanah M, Mahjoub A, et al. Amphetamine type stimulants use in the adult population of Tehran: Implications for long term rehabilitation. Iran Rehabil J. 2017;15(4):303-8. https://doi.org/10.29252/nrip.irj.15.4.303.
- 4.Dana S, Effatpanah M, Mahjoub A. The new epidemic problem of psychoactive drugs at drug treatment centers of Iran: Implications for education, prevention and treatment. Iran J Psychiatr Behav Sci. 2018;12(2). e63555. https://doi.org/10.5812/ijpbs.63555.
- 5.Massah O, Effatpanah M, Moradi A, Salehi M, Farhoudian A, Karami Z. Barriers to hepatitis C treatment among women in methadone treatment: A Study from Iran, the most populous Persian Gulf country. Addict Health. 2017;9(4):229-36. [PubMed ID: 30574286]. [PubMed Central ID: PMC6294482].
- 6.Salimi S, Effatpanah M, Mahjoub A. Motivational interviewing can facilitate entry to matrix treatment for methamphetamine dependence. Iran J Psychiatr Behav Sci. 2018;12(2). e63560. https://doi.org/10.5812/ijpbs.63560.
- 7.Effatpanah M, Moradi A. Methamphetamine dependence and technology-based interventions in Iran. Iran J Psychiatr Behav Sci. 2018;12(2). e62935. https://doi.org/10.5812/ijpbs.62935.
- 8.Sami S, Effatpanah M, Moradi A, Massah O. Matrix Model as an intensive rehabilitation in three methadone services in Iran. Iran Rehabil J. 2017;15(3):293-8. https://doi.org/10.29252/nrip.irj.15.3.293.
- 9.Khoramizadeh M, Effatpanah M, Mostaghimi A, Rezaei M, Mahjoub A, Shishehgar S. Treatment of amphetamine abuse/use disorder: A systematic review of a recent health concern. Daru. 2019;27(2):743-53. [PubMed ID: 31228128]. [PubMed Central ID: PMC6895313]. https://doi.org/10.1007/s40199-019-00282-3.
- 10.Shakiba K, Effatpanah M, Moradi A. Cognitive-behavioral therapy for methamphetamine dependence among methadone-maintained patients. Iran J Psychiatr Behav Sci. 2018;12(2). e63615. https://doi.org/10.5812/ijpbs.63615.
- 11.Massah O, Effatpanah M, Shishehgar S. Matrix model for methamphetamine dependence among Iranian female methadone patients: The first report from the most populated Persian Gulf country. Iran Rehabil J. 2017;15(3):193-8. https://doi.org/10.29252/nrip.irj.15.3.193.
Copyright
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Similar Articles
A Commentary on Subsidization of Drug Treatment Services in Iran: A New Approach
Nateghi S, Effatpanah H. A Commentary on Subsidization of Drug Treatment Services in Iran: A New Approach. Iran J Psychiatry Behav Sci. 2020;14(3):e105460. doi: https://doi.org/10.5812/ijpbs.105460
Iran’s Activities on Prevention, Treatment and Harm Reduction of Drug Abuse
Saberi Zafarghandi MB, Jadidi M, Khalili N. Iran’s Activities on Prevention, Treatment and Harm Reduction of Drug Abuse. Int J High Risk Behav Addict. 2015;4(4):e59737. doi: https://doi.org/10.5812/ijhrba.22863
Changing Harm Reduction Approaches Is Not a Choice; It Is Necessary to Survive
Naderi S, Charkhgard N, Rad P, Jafari S, Niknejad S. Changing Harm Reduction Approaches Is Not a Choice; It Is Necessary to Survive. Int J High Risk Behav Addict. 2023;12(3):e139609. doi: https://doi.org/10.5812/ijhrba-139609
Overview of National Drug Policy of Iran
Kebriaee-zadeh A. Overview of National Drug Policy of Iran. Iran J Pharm Res. 2022;2(3):e127624. doi: https://doi.org/10.22037/ijpr.2010.48
Diversity of Providing Services to Patients Suffering from Addiction Disorders is a Harm Reduction Thought, but...
Charkhgard N, Afghani A, Naderi S, Zahirian Moghadam S, Rad P. Diversity of Providing Services to Patients Suffering from Addiction Disorders is a Harm Reduction Thought, but.... Arch Neurosci. 2024;11(1):e143310. doi: https://doi.org/10.5812/ans-143310
Crossmark
Checking
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 0
Last Update: 3 weeks ago
- Scopus by Title (Ref): 0
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 2 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC